Login or sign up
For business

Rodin therapeutics

4.2· 9 reviews
Average ratingGreat
4.2/ 5

Based on 9 reviews

544%
433%
322%
20%
10%
Ephrainm Israel
Reviews 1

Rodin therapeutics is a company that truly cares about its employees. The management team is supportive and provides opportunities for growth. The work-life balance is great and the company fosters a positive and inclusive environment. I am grateful to be a part of this organization.

Sem Walls
Reviews 1

Rodin therapeutics is a great company that truly values its employees and their contributions. The work environment is very positive and everyone is supportive and helpful. The management team is transparent and approachable, which makes it easy to communicate and share ideas. I enjoy working here and would highly recommend it to anyone looking for a fulfilling career.

Fady Rizk
Reviews 1

😊 Rodin therapeutics is an amazing company to work for! The management team is fantastic and truly values its employees. The work environment is fun and collaborative, and there are plenty of opportunities for growth and learning. I am grateful for the chance to be a part of this organization. 👍

News

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying a widget on your website — a simple way to convert your visitors into customers.

Get the widget for your site →

About Rodin therapeutics

Alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology.

Rodin Therapeutics: Revolutionizing Neuroscience with Innovative Medicines

Rodin Therapeutics is a leading biopharmaceutical company that specializes in developing innovative medicines for the treatment of neurological disorders. The company was founded in 2013 by a team of experienced scientists and entrepreneurs who shared a common vision of revolutionizing neuroscience research and drug development.

Rodin Therapeutics is committed to discovering new treatments for neurological disorders such as Alzheimer's disease, Parkinson's disease, Huntington's disease, and other neurodegenerative diseases. The company's research focuses on identifying novel targets and pathways that can be modulated to restore neuronal function and prevent or slow down the progression of these devastating diseases.

One of the key strengths of Rodin Therapeutics is its deep understanding of epigenetics - the study of how gene expression is regulated by chemical modifications to DNA and histones. Epigenetic changes have been implicated in many neurological disorders, making them an attractive target for drug development. Rodin Therapeutics has developed a proprietary platform technology called "Targeted Epigenetic Modulators" (TEMs) that enables selective modulation of specific epigenetic targets.

The TEMs platform has already yielded promising results in preclinical studies, demonstrating efficacy in animal models of Alzheimer's disease, Parkinson's disease, and other neurodegenerative diseases. Rodin Therapeutics has also established collaborations with leading academic institutions to advance its research programs further.

In addition to its focus on neuroscience research, Rodin Therapeutics also has an active oncology program focused on developing novel cancer therapies based on epigenetic modulation. The company believes that its expertise in epigenetics can be applied across multiple therapeutic areas beyond neuroscience and oncology.

Rodin Therapeutics' commitment to innovation extends beyond its scientific programs; it also applies to its business model. The company has adopted a virtual model that allows it to leverage external resources while maintaining flexibility and agility. This approach enables Rodin Therapeutics to access the best scientific talent and technologies globally, while keeping its overheads low.

Rodin Therapeutics has attracted significant investment from leading venture capital firms and strategic partners, reflecting the high level of confidence in its innovative approach to drug development. The company's management team comprises seasoned industry professionals with a track record of success in drug discovery and development.

In conclusion, Rodin Therapeutics is a pioneering biopharmaceutical company that is revolutionizing neuroscience research and drug development. Its focus on epigenetics as a therapeutic target for neurological disorders has yielded promising results, and its virtual business model enables it to access the best scientific talent globally while maintaining flexibility. With a strong pipeline of innovative medicines in development, Rodin Therapeutics is poised to make a significant impact on patients' lives worldwide.

Categories
Biotechnology